Advantages of SenoRx Contura over Mammosite Breast Brachytherapy system.

Implications: SenoRx has released the Contura system which provides a superior system when compared to the Mammosite Breast Brachytherapy System.  These advantages include: 1.  Better dosimetry, opening the door for more patients to be treated by avoiding the elimination of some patients due to skin spacing and chest wall considerations. 2. Better reimbursement due to the use of multiple dwell positions used versus just one with the Mammosite system. 3  Ability to drain fluid collection via drainage ports of the Contura system that are not available with the Mammosite system. The SenoRx system is poised to take a large percentage of the market share away from Mammosite.

Analysis: The advantages listed above will lead the majority of oncologist to swith to the Contura system within the next year or so, and will open the door to more patients being treated with this technology.